Publications by authors named "Cierra N Sharp"

Claim this Profile
L
Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity.
Andrew Orwick, Sophia M Sears, Cierra N Sharp, Mark A Doll, Parag P Shah

Am J Physiol Renal Physiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.
Sophia M Sears, Tess V Dupre, Parag P Shah, Deanna L Davis, Mark A Doll, Cierra N Sharp

J Lipid Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing Utilization.
Cierra N Sharp, Anita Fletcher, Penn Muluhngwi, James Snyder, Mark W Linder

J Appl Lab Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury.
Sophia M Sears, Cierra N Sharp, Austin Krueger, Gabrielle B Oropilla, Douglas Saforo

Am J Physiol Renal Physiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELISA-based detection of Open Reading Frame protein 1 in patients at risk of developing lung cancer.
Cierra N Sharp, Erik A Korte, Keivan Hosseinejad, Jennifer Pitman, Afsaneh Lavasanifar

Clin Chim Acta· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
Penn Muluhngwi, Cierra N Sharp, Nicole Pozzi, Ronald J Elin, Saeed A Jortani

J Appl Lab Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypharmacy: a healthcare conundrum with a pharmacogenetic solution.
Cierra N Sharp, Mark W Linder, Roland Valdes

Crit Rev Clin Lab Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics and therapeutics.
Afsaneh Lavasanifar, Cierra N Sharp, Erik A Korte, Tyler Yin, Keivan Hosseinnejad

Clin Chim Acta· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration.
Cierra N Sharp, Mark Doll, Tess V Dupre, Levi J Beverly, Leah J Siskind

Am J Physiol Renal Physiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin Effects in Lung Adenocarcinoma-bearing Mice, Alone and in Combination with Erlotinib.
Cierra N Sharp

Toxicol Pathol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease.
Cierra N Sharp, Mark A Doll, Judit Megyesi, Gabrielle B Oropilla, Levi J Beverly

Am J Physiol Renal Physiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing better mouse models to study cisplatin-induced kidney injury.
Cierra N Sharp, Leah J Siskind

Am J Physiol Renal Physiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.
Tess V Dupre, Mark A Doll, Parag P Shah, Cierra N Sharp, Deanna Siow

J Lipid Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated administration of low-dose cisplatin in mice induces fibrosis.
Cierra N Sharp, Mark A Doll, Tess V Dupre, Parag P Shah, Marimuthu Subathra

Am J Physiol Renal Physiol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suramin protects from cisplatin-induced acute kidney injury.
Tess V Dupre, Mark A Doll, Parag P Shah, Cierra N Sharp, Alex Kiefer

Am J Physiol Renal Physiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis